Given REF is incompatible with our hg38 reference sequence (N). Please double check if it's correct.
Y-1623310-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The ENST00000711210.1(ASMT):c.241A>G(p.Lys81Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: not found (cov: )
Consequence
ASMT
ENST00000711210.1 missense
ENST00000711210.1 missense
Scores
1
Clinical Significance
Conservation
PhyloP100: 0.168
Genes affected
ASMT (HGNC:750): (acetylserotonin O-methyltransferase) This gene belongs to the methyltransferase superfamily, and is located in the pseudoautosomal region (PAR) at the end of the short arms of the X and Y chromosomes. The encoded enzyme catalyzes the final reaction in the synthesis of melatonin, and is abundant in the pineal gland. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (Cadd=0.028).
BP6
Variant Y-1623310-A-G is Benign according to our data. Variant chrY-1623310-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 599440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASMT_1 | NM_001171038.2_1 | c.241A>G | p.Lys81Glu | missense_variant | 2/9 | |||
ASMT_1 | NM_001416525.1_1 | c.241A>G | p.Lys81Glu | missense_variant | 2/8 | |||
ASMT_1 | NM_001171039.1_1 | c.241A>G | p.Lys81Glu | missense_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASMT | ENST00000711210.1 | c.241A>G | p.Lys81Glu | missense_variant | 2/9 | 1 | ENSP00000518608.1 | |||
ASMT | ENST00000711209.1 | c.241A>G | p.Lys81Glu | missense_variant | 2/8 | 1 | ENSP00000518607.1 | |||
ASMT | ENST00000711208.1 | c.241A>G | p.Lys81Glu | missense_variant | 2/7 | 1 | ENSP00000518606.1 |
Frequencies
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Sep 05, 2017 | BS3, BP4; This alteration was found through a well-established in vitro or in vivo functional study to shown no damaging effect on protein function or splicing, and is predicted to be tolerated by multiple functional prediction tools. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
CADD
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at